<DOC>
	<DOCNO>NCT02234492</DOCNO>
	<brief_summary>The purpose study determine whether use rosuvastatin Human Immunodeficiency Virus ( HIV ) infect individual lower inflammation blood vessel , improve blood circulation small artery provide nutrient heart muscle improve neurocognitive function .</brief_summary>
	<brief_title>The Effects Statin Therapy Coronary Flow Reserve Inflammatory Markers HIV-Positive Patients</brief_title>
	<detailed_description>HIV chronic inflammatory disease . Patients HIV high risk cardiovascular disease ( CVD ) may relate state chronic inflammation . HIV infected individual four time high risk suffer heart attack ( also know acute coronary syndrome ) . The medicine rosuvastatin , commonly use treat high cholesterol , show reduce inflammation artery general population also patient high risk heart problem . 72 subject HIV infection enrol divide 2 group 36 . Group 1 : Treatment Group : Participants receive low dose rosuvastatin , 10mg , 6 month addition current medical therapy . Group 2 : Control Group : Participants receive rosuvastatin 6 month continue current medical therapy . Participants group undergo blood test , Myocardial Contrast Echocardiography ( MCE ) scan Positron Emission Tomography/Computed Tomography PET/CT scan use radioactive tracer call fluorodeoxyglucose ( FDG-PET ) , monocyte serum cytokine study baseline 6 month . 10 subject without HIV also enrol undergo monocyte serum cytokine blood test , comparison .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>4090 year age document evidence HIV infection standard antiretroviral therapy ( ART ) &gt; 1 year viral load persistently limit detection ART current Cluster Differentiation Antigen 4 ( CD4 ) count &gt; 350 cells/microlitre baseline Framingham risk score 1020 % uncontrolled diabetes mellitus ( glycated hemoglobin ( HbA1C ) &gt; 6.5 % fast glucose &gt; 7.0 mmol/L ) uncontrolled hypertension ( systolic blood pressure &gt; 160 diastolic blood pressure &gt; 90 ) know coronary artery disease ( CAD ) e.g . previous myocardial infarction , revascularization procedure , history angina chronic renal failure ( glomerular filtration rate ( GFR ) &lt; 60 ml/min ) total cholesterol &gt; 5.8 mmol/L Lowdensity lipoprotein ( LDL ) cholesterol &gt; 4.0 mmol/L already receive statin baseline dyslipidemia pregnant lactate active untreated Hepatitis B C diagnosis clinical evidence concomitant inï¬‚ammatory/autoimmune disease patient baseline demonstrate regional perfusion abnormality ( confine individual coronary territory ) follow stress MCE exclude management accord local best practice guideline</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Human immunodeficiency virus ( HIV )</keyword>
	<keyword>Statin therapy</keyword>
	<keyword>Cardiovascular disease ( CVD )</keyword>
	<keyword>Coronary Flow Reserve ( CFR )</keyword>
	<keyword>Positron Emission Tomography ( PET )</keyword>
	<keyword>Myocardial contrast echocardiography ( MCE )</keyword>
</DOC>